Hopman, W.M.
,
Berger, C.
Joseph, L.
Morin, S.N.
Towheed, T.
Anastassiades, T.
Adachi, J.D.
Hanley, D.A.
Prior, J.C.
Goltzman, D.
Article History
Received: 4 January 2019
Accepted: 22 April 2019
First Online: 8 May 2019
Compliance with ethical standards
:
: Wilma M. Hopman, Claudie Berger, Lawrence Joseph, Tanveer Towheed, Tassos Anastassiades, David A. Hanley, Jerilynn Prior, and David Goltzman declare that they have no conflict of interest.Suzanne N Morin declares that she has conflicts of interest but that they do not pertain to the current paper. She receives research grants paid to the Research Institute of the McGill University Health Centre from Merck and Amgen.Jonathan D. Adachi declares that he has conflicts of interest but he does not believe that they pertain to the current paper. He is on the Amgen speaker’s bureau, conducts clinical trials with them and is a scientific advisor. In addition he is a past president of Osteoporosis Canada and sits on the board of directors, and is a scientific advisor for the International Osteoporosis Foundation.